SERA

Sera Prognostics, Inc.

9.10 USD
-0.36 (-3.81%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Sera Prognostics, Inc. stock is up 55.03% since 30 days ago. The next earnings date is Mar 20, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 2 February’s closed higher than January.

About Sera Prognostics, Inc.

Sera Prognostics, Inc. develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.